Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 33 | 2020 | 3158 | 1.920 |
Why?
|
| Magnetic Resonance Imaging | 27 | 2018 | 3479 | 1.690 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 122 | 0.650 |
Why?
|
| Breast | 8 | 2020 | 303 | 0.640 |
Why?
|
| Contrast Media | 14 | 2015 | 988 | 0.630 |
Why?
|
| Mammography | 4 | 2017 | 494 | 0.540 |
Why?
|
| Calcinosis | 1 | 2017 | 222 | 0.480 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2012 | 166 | 0.450 |
Why?
|
| Gadolinium DTPA | 8 | 2015 | 233 | 0.440 |
Why?
|
| Sensitivity and Specificity | 11 | 2017 | 1923 | 0.410 |
Why?
|
| ROC Curve | 8 | 2020 | 775 | 0.370 |
Why?
|
| Retrospective Studies | 17 | 2018 | 10186 | 0.330 |
Why?
|
| Image Enhancement | 6 | 2015 | 505 | 0.320 |
Why?
|
| Middle Aged | 32 | 2020 | 27620 | 0.310 |
Why?
|
| Ultrasonography, Mammary | 3 | 2018 | 84 | 0.300 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 337 | 0.270 |
Why?
|
| Aged | 22 | 2018 | 20469 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2015 | 629 | 0.260 |
Why?
|
| Female | 33 | 2020 | 48771 | 0.250 |
Why?
|
| Adult | 24 | 2020 | 27953 | 0.240 |
Why?
|
| Mastectomy, Segmental | 2 | 2012 | 108 | 0.240 |
Why?
|
| Observer Variation | 4 | 2016 | 571 | 0.230 |
Why?
|
| Reproducibility of Results | 9 | 2018 | 2718 | 0.220 |
Why?
|
| Biopsy | 6 | 2015 | 1177 | 0.220 |
Why?
|
| Humans | 37 | 2020 | 93607 | 0.180 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 7073 | 0.180 |
Why?
|
| Kinetics | 5 | 2016 | 1470 | 0.170 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 1546 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 299 | 0.150 |
Why?
|
| Lymphatic Metastasis | 4 | 2016 | 505 | 0.150 |
Why?
|
| Echo-Planar Imaging | 1 | 2020 | 51 | 0.150 |
Why?
|
| Breast Diseases | 2 | 2016 | 99 | 0.140 |
Why?
|
| Nipples | 1 | 2018 | 37 | 0.140 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2017 | 15 | 0.130 |
Why?
|
| Cryosurgery | 1 | 2018 | 67 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2006 | 2592 | 0.130 |
Why?
|
| Resuscitation | 1 | 1998 | 130 | 0.130 |
Why?
|
| Axilla | 2 | 2013 | 109 | 0.110 |
Why?
|
| Entropy | 1 | 2015 | 42 | 0.110 |
Why?
|
| Probability | 1 | 2015 | 355 | 0.110 |
Why?
|
| Carcinoma | 1 | 2018 | 439 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 302 | 0.110 |
Why?
|
| Heart Arrest | 1 | 1998 | 311 | 0.100 |
Why?
|
| Algorithms | 3 | 2011 | 1954 | 0.100 |
Why?
|
| Hyperostosis, Sternocostoclavicular | 1 | 1993 | 1 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 1 | 2015 | 449 | 0.090 |
Why?
|
| Chest Pain | 1 | 1993 | 45 | 0.090 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 2018 | 0.090 |
Why?
|
| Water | 2 | 2012 | 306 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2018 | 512 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 572 | 0.080 |
Why?
|
| False Negative Reactions | 1 | 2010 | 59 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 504 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 889 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 1 | 2011 | 217 | 0.080 |
Why?
|
| Fourier Analysis | 1 | 2009 | 122 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 53 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2016 | 548 | 0.070 |
Why?
|
| Prognosis | 4 | 2015 | 3913 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 1262 | 0.060 |
Why?
|
| Area Under Curve | 2 | 2020 | 335 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 226 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 608 | 0.060 |
Why?
|
| Hyponatremia | 1 | 2003 | 30 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2005 | 1525 | 0.050 |
Why?
|
| Alcoholism | 1 | 2003 | 188 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1723 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3835 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1661 | 0.040 |
Why?
|
| Radiography | 2 | 2012 | 790 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2015 | 917 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1715 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2005 | 9108 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 1449 | 0.040 |
Why?
|
| Hospitals, Municipal | 1 | 1998 | 1 | 0.030 |
Why?
|
| Emergency Medical Technicians | 1 | 1998 | 14 | 0.030 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 2018 | 8 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 96 | 0.030 |
Why?
|
| Ventricular Fibrillation | 1 | 1998 | 67 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1998 | 64 | 0.030 |
Why?
|
| Sudden Infant Death | 1 | 1998 | 34 | 0.030 |
Why?
|
| Electric Countershock | 1 | 1998 | 74 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 4563 | 0.030 |
Why?
|
| Japan | 1 | 1998 | 299 | 0.030 |
Why?
|
| Patient Transfer | 1 | 1998 | 108 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1998 | 172 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 225 | 0.030 |
Why?
|
| Mastectomy | 1 | 2018 | 262 | 0.030 |
Why?
|
| Heart Diseases | 1 | 1998 | 257 | 0.030 |
Why?
|
| Lung Diseases | 1 | 1998 | 283 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2018 | 407 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1171 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1995 | 68 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 1995 | 95 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1998 | 247 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 446 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 69 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2005 | 2564 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 758 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 990 | 0.030 |
Why?
|
| Survival Rate | 1 | 1998 | 1950 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 1998 | 582 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1993 | 189 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 1907 | 0.020 |
Why?
|
| Fats | 1 | 2011 | 12 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 385 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 316 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1993 | 269 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 3061 | 0.020 |
Why?
|
| Infant | 1 | 1998 | 3222 | 0.020 |
Why?
|
| Mass Screening | 1 | 2016 | 711 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2011 | 125 | 0.020 |
Why?
|
| Injections | 1 | 2010 | 124 | 0.020 |
Why?
|
| Psoriasis | 1 | 1993 | 254 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2010 | 117 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 399 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2010 | 97 | 0.020 |
Why?
|
| Male | 4 | 2003 | 44578 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 1993 | 755 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1913 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 702 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 5911 | 0.010 |
Why?
|
| Thallium Radioisotopes | 1 | 1995 | 4 | 0.010 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 1995 | 7 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 51 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1995 | 87 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1995 | 188 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1995 | 232 | 0.010 |
Why?
|
| Heart | 1 | 1995 | 522 | 0.010 |
Why?
|